LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Authors: Musher, Benjamin L ^*, Rowinsky, Eric K, Smaglo, Brandon G, Abidi, Wasif, Othman, Mohamed, Patel, Kalpesh, Jawaid, Salmaan, Jing, James, Brisco, Amanda, Leen, Ann M, Wu, Mengfen, Sandin, Linda C, Wenthe, Jessica, Eriksson, Emma, Ullenhag, Gustav J, Grilley, Bambi, Leja-Jarblad, Justyna, Hilsenbeck, Susan G, Brenner, Malcolm K, Loskog, Angelica S I

Source: In The Lancet Oncology April 2024 25(4):488-500

Predicting immune‐related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study

Authors: Olsson Ladjevardi, Cecilia, Koliadi, Anthoula, Rydén, Viktoria, Inan El‐Naggar, Ali, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Source: Cancer medicine. 12(12):13217-13224

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187849680.0x000001&indx=1&recIds=ETOCvdc_100187849680.0x000001

Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study

Authors: Naeser, Ylva, Mikiver, Rasmus, Ingvar, Christian, Lambe, Mats, Ullenhag, Gustav J.

Source: In eClinicalMedicine November 2023 65

Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

Authors: Backlund, Ellen, Yang, Muyi, Grozman, Vitali, Masucci, Giuseppe, Falkenius, Johan, Eriksson, Hanna, Jovanovic, Braslav, Hammarlund, Katarina, Isacsson, Ulf, Radu, Calin, Abel, Edvard, Karlsson, Kristin, Palanco Zamora, Ricardo, Wersäll, Peter, Edbäck, Ulrika, Wickström, Stina, Darai Ramqvist, Eva, Egyhazi Brage, Suzanne, Kiessling, Rolf, Viktorsson, Kristina, Franzén, Bo, Lewensohn, Rolf, Olofsson Bagge, Roger, Ullenhag, Gustav J., Ny, Lars, Lindberg, Karin, Helgadottir, Hildur

Source: Acta oncologica. 61(7):869-873

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153402367.0x000001&indx=1&recIds=ETOCvdc_100153402367.0x000001

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.

Authors: Ladjevardi, Cecilia Olsson, Skribek, Marcus, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Source: Cancer Immunology, Immunotherapy; Jan2025, Vol. 74 Issue 1, p1-8, 8p

Cancer survival in women diagnosed with pregnancy-associated cancer: An overview using nationwide registry data in Sweden 1970–2018

Authors: Johansson, Anna L.V., Fredriksson, Irma, Mellemkjaer, Lene, Stensheim, Hanne, Lähteenmäki, Päivi, Winther, Jeanette F., Ullenhag, Gustav J., Lundberg, Frida E.

Source: In European Journal of Cancer September 2021 155:106-115

Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer

Authors: Elfving, Hedvig, Broström, Erika, Moens, Lotte N.J., Almlöf, Jonas, Cerjan, Dijana, Lauter, Gilbert, Nord, Helena, Mattsson, Johanna S.M., Ullenhag, Gustav J., Strell, Carina, Backman, Max, La Fleur, Linnéa, Brunnström, Hans, Botling, Johan, Micke, Patrick ^*

Source: In Lung Cancer January 2021 151:53-59

Surgery of metastatic melanoma after systemic therapy – the SUMMIST trial: study protocol for a randomized controlled trial

Authors: Holmberg, Carl Jacob, Katsarelias, Dimitrios, Jespersen, Henrik, Carneiro, Ana, Elander, Nils O., Helgadottir, Hildur, Isaksson, Karolin, Jansson, Malin, Wirén, Sara, Ullenhag, Gustav J., Ny, Lars, Olofsson Bagge, Roger

Source: Acta oncologica. 60(1):52-55

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122051629.0x000001&indx=1&recIds=ETOCvdc_100122051629.0x000001

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment

Authors: Derksen, Jeroen W.G., Warren, Graham W., Jordan, Karin, Rauh, Stefan, Vera García, Ruth, O'Mahony, Deirdre, Ahmed, Samreen, Vuylsteke, Peter, Radulovic, Sinisa, Tsoukalas, Nikolaos, Wysocki, Piotr J., Borner, Markus, Cesas, Alvydas, Elme, Anneli, Minn, Heikki, Ullenhag, Gustav J., Roodhart, Jeanine M.L., Koopman, Miriam, May, Anne M.

Source: In European Journal of Cancer October 2020 138:99-108

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

Authors: Tholander, Bengt, Koliadi, Anthoula, Botling, Johan, Dahlstrand, Hanna, Von Heideman, Anne, Ahlström, Håkan, Öberg, Kjell, Ullenhag, Gustav J.

Source: Upsala journal of medical sciences. 125(4):325-329

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110759384.0x000001&indx=1&recIds=ETOCvdc_100110759384.0x000001

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness.

Authors: Ladjevardi, Cecilia Olsson, Koliadi, Anthoula, Rydén, Viktoria, El-Naggar, Ali Inan, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Source: Frontiers in Oncology; 2024, p1-8, 8p

Subject Terms: DRUG side effects, CANCER patients, TREATMENT effectiveness, NON-small-cell lung carcinoma, CANCER treatment

First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies

Authors: Irenaeus, Sandra M. M., Nielsen, Dorte, Ellmark, Peter, Yachnin, Jeffrey, Deronic, Adnan, Nilsson, Anneli, Norlén, Per, Veitonmäki, Niina, Wennersten, Camilla S., Ullenhag, Gustav J.

Source: International journal of cancer. 145(5):1189-1199

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100085061223.0x000001&indx=1&recIds=ETOCvdc_100085061223.0x000001

Discrepancy in BRAF status among patients with metastatic malignant melanoma: A meta-analysis

Authors: Valachis, Antonis, Ullenhag, Gustav J.

Source: In European Journal of Cancer August 2017 81:106-115

The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis.

Authors: Rydén, Viktoria, El‐Naggar, Ali Inan, Koliadi, Anthoula, Ladjevardi, Cecilia Olsson, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.

Source: Pigment Cell & Melanoma Research; May2024, Vol. 37 Issue 3, p352-362, 11p

Subject Terms: IMMUNE checkpoint inhibitors, MELANOMA, TEMOZOLOMIDE, DACARBAZINE, PROGRESSION-free survival, OVERALL survival

CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including 'find‐me', 'eat‐me', and 'kill‐me' signalling.

Authors: Naseri, Sedigheh, Cordova, Mariela Mejia, Wenthe, Jessica, Lövgren, Tanja, Eriksson, Emma, Loskog, Angelica, Ullenhag, Gustav J.

Source: Journal of Cellular & Molecular Medicine; Apr2024, Vol. 28 Issue 7, p1-13, 13p

Risk factors for the increasing incidence of pregnancy‐associated cancer in Sweden – a population‐based study.

Authors: Lundberg, Frida E., Stensheim, Hanne, Ullenhag, Gustav J., Sahlgren, Hanna Milerad, Lindemann, Kristina, Fredriksson, Irma, Johansson, Anna L. V.

Source: Acta Obstetricia et Gynecologica Scandinavica; Apr2024, Vol. 103 Issue 4, p669-683, 15p

Subject Terms: MATERNAL age, BODY mass index, POISSON regression, VITAL records (Births, deaths, etc.), MELANOMA

Geographic Terms: SWEDEN

Mortality in women with pregnancy-associated malignant melanoma

Authors: Johansson, Anna L.V., Andersson, Therese M-L., Plym, Anna, Ullenhag, Gustav J., Møller, Henrik, Lambe, Mats

Source: In Journal of the American Academy of Dermatology December 2014 71(6):1093-1101

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma

Authors: Naeser, Ylva, Helgadottir, Hildur, Brandberg, Yvonne, Hansson, Johan, Bagge, Roger Olofsson, Elander, Nils O., Ingvar, Christian, Isaksson, Karolin, Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, del Val Munoz, Olga, Valachis, Antonis, Jansson, Malin, Sparring, Charlotte, Ohlsson, Lars, Dyrke, Ulf, Papantoniou, Dimitrios, Sundin, Anders, Ullenhag, Gustav J.

Source: BMC cancer. 20(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190452213.0x000001&indx=1&recIds=ETOCvdc_100190452213.0x000001

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Authors: Niinivirta, Marjut, Georganaki, Maria, Enblad, Gunilla, Lindskog, Cecilia, Dimberg, Anna, Ullenhag, Gustav J.

Source: BMC cancer. 20(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100171661127.0x000001&indx=1&recIds=ETOCvdc_100171661127.0x000001

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.

Authors: Helgadottir, Hildur, Ny, Lars, Ullenhag, Gustav J, Falkenius, Johan, Mikiver, Rasmus, Bagge, Roger Olofsson, Isaksson, Karolin

Source: JNCI: Journal of the National Cancer Institute; Sep2023, Vol. 115 Issue 9, p1077-1084, 8p

Subject Terms: MELANOMA, OVERALL survival, SURVIVAL rate, MEDICAL registries, THERAPEUTICS, CONFIDENCE intervals

Geographic Terms: SWEDEN